Moderna Dives As FDA Delays Covid Vaccine In Teens To Investigate 'Rare' Side Effect

Moderna Dives As FDA Delays Covid Vaccine In Teens To Investigate 'Rare' Side Effect

Source: 
Investors Business Daily
snippet: 

Moderna stock toppled Monday after the Food and Drug Administration delayed authorizing its Covid vaccine in teens, citing the risk for myocarditis.